- ISIN
- US5747951003
- CUSIP
- 574795100
- Delisting Date
- Jun 11, 2026
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Aug 8, 2007
Highlights
- Market Cap
- $9.47B
- Enterprise Value
- $9.79B
- EPS (TTM)
- $1.41
- PE Ratio
- 127.36
- Total Revenue (TTM)
- $1.56B
- Gross Profit (TTM)
- $962.00M
- EBITDA (TTM)
- $336.40M
- Year Range
- $125.94 - $179.99
- Target Price
- $187.50
- ROA (TTM)
- 4.64%
- ROE (TTM)
- 9.67%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MASI Performance Chart
Loading charts...
Returns By Period
Masimo Corporation
- 1D
- —
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.42%
- 1M
- 1.94%
- 6M
- 8.74%
- YTD
- 10.66%
- 1Y
- 21.02%
- 3Y*
- 19.50%
- 5Y*
- 11.63%
- 10Y*
- 13.41%
MASI Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.59% | 27.69% | 1.44% | 0.31% | 0.01% | 0.84% | 38.36% | ||||||
| 2025 | 5.40% | 8.35% | -11.74% | -3.39% | 0.96% | 3.52% | -8.58% | -9.16% | 5.61% | -4.68% | 1.27% | -8.68% | -21.32% |
| 2024 | 10.01% | -0.31% | 14.24% | -8.47% | -7.37% | 1.16% | -15.05% | 9.85% | 13.45% | 8.01% | 19.81% | -4.20% | 41.03% |
| 2023 | 14.96% | -1.63% | 10.30% | 2.49% | -14.43% | 1.67% | -25.68% | -6.56% | -23.28% | -7.47% | 15.57% | 25.01% | -20.78% |
| 2022 | -24.90% | -28.39% | -7.56% | -22.38% | 24.31% | -6.95% | 10.65% | 1.60% | -3.90% | -6.77% | 10.14% | 2.08% | -49.47% |
| 2021 | -4.64% | -2.03% | -8.40% | 1.31% | -7.34% | 12.45% | 12.35% | -0.31% | -0.31% | 4.74% | -1.91% | 5.27% | 9.09% |
Benchmark Metrics
Masimo Corporation has an annualized alpha of 11.16%, beta of 0.88, and R2 of 0.22 versus S&P 500 Index. Calculated based on daily prices since August 08, 2007.
- This stock captured 108.25% of S&P 500 Index gains but only 88.32% of its losses - a favorable profile for investors.
- R2 of 0.22 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 11.16%
- Beta
- 0.88
- R²
- 0.22
- Upside Capture
- 108.25%
- Downside Capture
- 88.32%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Masimo Corporation (MASI) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MASI | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.30 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.28 | — |
| Martin ratioReturn relative to average drawdown | — | 9.88 | — |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Masimo Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Masimo Corporation was 74.70%, occurring on Oct 16, 2023. The portfolio has not yet recovered.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -74.70%Oct 2023 | 1y 10mo | — | 4y 7moNov 2021 - now |
2011 bear market2011 | -53.25%Nov 2011 | 3y 2mo | 3y 6mo | 6y 8moSep 2008 - Jun 2015 |
Financial crisis2007–2009 | -40.03%Apr 2008 | 3mo 22d | 4mo 27d | 8mo 19dDec 2007 - Sep 2008 |
2021 bear market2021 | -26.52%Jun 2021 | 4mo 28d | 2mo 17d | 7mo 15dJan 2021 - Aug 2021 |
2017 bear market2017 | -21.70%Aug 2017 | 3mo 28d | 11mo 9d | 1y 3moMay 2017 - Aug 2018 |
Drawdown Indicators
| MASI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | -0.45% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.71% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.09% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Masimo Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Masimo Corporation is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for MASI, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, MASI has a P/E ratio of 127.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MASI relative to other companies in the Medical Instruments & Supplies industry. Currently, MASI has a P/S ratio of 6.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for MASI in comparison with other companies in the Medical Instruments & Supplies industry. Currently, MASI has a P/B value of 12.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with MASI
Add Masimo Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MASI